NURS-6630C-9/NURS-6630N-9-Approaches to Treatment2020 Spring MIDTERM 72 OUT OF 75 {GRADED A PLUS}

Course NURS-6630C-9/NURS-6630N-9-
Approaches to Treatment2020 Spring I I I I


Test Week I6 IMidterm IExam
Status Completed
Attempt 72 I out I of I 75 I points
IS core


Time 1 Ihour, I36 Iminutes Iout Iof I2 Ihours
IElapsed


Results Submitted IAnswers
I

IDisplaye

d
• Question 1 I

1 Iout Iof I1 I points
Mr. McCullin is 64 years old with Parkinson’s disease. The
I I I I I I I I I


PMHNP caring for Mr. McCullin wants to start him on a
I I I I I I I I I I I


dopamine agonist to help manage and treat his condition. The
I I I I I I I I I I


PHMNP selects this agent because of which action it hason
I I I I I I I I I I I


patients like Mr. McCullin?
I I I I




Selected D.
IA nswer: D2 receptors are the primary binding site for dopamine
I I I I I I I I


agonists.
I



• Question 2 I

1 Iout Iof I1 I points


Ms. I Hill I is I currently I being I treated I for I schizophrenia I but I has I stopped Itaking
Iher I medications I due I to I some I side I effects I she I claims I she I was

Iexperiencing. I She I presents I to I the I clinic I today I with I worsening I symptoms.

IShe Iis I experiencing Ianhedonia, I agitation, Iattentional Iimpairment, Iand

Iaffective I blunting. I Which I one I of I the I symptoms I mentioned I is I considered I a

Iprogressive Isymptom Iof Ischizophrenia?




Selected B.
IA nswer: Agitation
• Question 3 I


1 Iout Iof I1 I points

, The PMHNP evaluates the patient for “fear conditioning” when
I I I I I I I I


he asks:
I I




Selected A.
IA nswer: Have you ever experienced any
I I I I


varietyof trauma?
I I I



• Question 4 I


1 Iout Iof I1 I points
While genes have potential to modify behavior, behavior canalso
I I I I I I I I I


modify genes. How do genes impact this process?
I I I I I I I I




Selected B.
IA nswer: Changes made to proteins lead to changes in I I I I I I I


behavior.
I



• Question 5 I


1 Iout Iof I1 I points
The PMHNP is caring for a patient with schizophrenia and is
I I I I I I I I I I


considering a variety of treatment approaches. The PHMNP
I I I I I I I I


selects a viable treatment that is consistent with the
I I I I I I I I I


“dopamine hypothesis of schizophrenia.” What action does
I I I I I I I


the PMHNP anticipate this treatment having on the patient?
I I I I I I I I I




Selected B.
IA nswer: Hyperactivity in the mesolimbic dopamine pathway I I I I I


mediates the positive symptoms ofschizophrenia.
I I I I I I



• Question 6 I


1 Iout Iof I1 I points
A patient is diagnosed with schizophrenia. What rises the patient’s
I I I I I I I I I


potential to mediate the cognitive symptoms of the disease?
I I I I I I I I I




Selected A.
IA nswer: Achieving underactivity of the mesocorticol I I I I


projections to the prefrontal cortex
I I I I I



• Question 7 I

1 Iout Iof I1 I points

, The PMHNP is assessing a patient in the psychiatric
I I I I I I I I


emergency room. The patient tells the PMHNP that he does
I I I I I I I I I I


not understand why his depression has not lifted after being
I I I I I I I I I I


on four different antidepressants over the course of a year.
I I I I I I I I I I


Which of the following symptoms can be residual symptomsfor
I I I I I I I I I I


patients who do not achieve remission with major
I I I I I I I I


depressive disorder?
I I




Selected D.
IA nswer: A and I


C
I



• Question 8 I


1 Iout Iof I1 I points
Though medications have the ability to target neurotransmitter releaseinto
I I I I I I I I I


the synapse by the presynaptic neuron it is not always necessary. The PMHNP
I I I I I I I I I I I I I


understands that this is because:
I I I I I



Selected C.
IA nswer: Neurotransmitters can spread by I I I


diffusion.
I



• Question 9 I

1 Iout Iof I1 I points
A patient diagnosed with PTSD is prescribed propranolol (Inderal)
I I I I I I I I


and the PMHNP understands that he was prescribedthis
I I I I I I I I I


medication for what purpose:
I I I I




Selected B.
IA nswer: Beta blockers are linked to I I I I


reconsolidation.
I



• Question 10 I

1 Iout Iof I1 I points
A patient presents with frequent episodes of mania. Which
I I I I I I I I


statement describes an appropriate treatment approach for
I I I I I I I


this patient?
I I




Selected B.
IA nswer: “The patient could benefit from an I I I I I


anticonvulsant.”
I